aid: infinitopes accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/infinitopes.png name: Infinitopes description: 'Infinitopes is an Oxford University spinout biotech company (founded 2021, based at the BioEscalator in Oxford, UK) developing off-the-shelf precision cancer vaccines aimed at preventing deaths from cancer metastases. Its proprietary Precision Immunomics platform identifies tumor-specific antigens by integrating immunopeptidomics, advanced laboratory methods, machine learning, and validated biological testing across cancer types, paired with engineered viral vectors that elicit protective CD8 T-cell responses. Surfaced in the API Evangelist network as a portfolio company of Amplify Partners (also supported by Cancer Research UK). This is a digital-biology company profile; Infinitopes publishes no public developer portal, API documentation, SDKs, or technical integration surface at this time.' url: https://raw.githubusercontent.com/api-evangelist/infinitopes/refs/heads/main/apis.yml x-type: company x-source: vc-portfolio x-backed-by: - amplify-partners x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-19' tags: - Company - Digital Biology - Biotechnology - Cancer Vaccines - Immunotherapy - Immunomics - Machine Learning - Oxford apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: DomainSecurity url: security/infinitopes-domain-security.yml - type: Website url: https://infinitopes.com - type: Blog url: https://infinitopes.com/news - type: Support url: https://infinitopes.com/contact - type: PrivacyPolicy url: https://infinitopes.com/privacy x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence